These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 16619467)

  • 41. Risks and benefits, rights and responsibilities: a history of the recombinant DNA research controversy.
    Swazey JP; Sorenson JR; Wong CB
    South Calif Law Rev; 1978 Sep; 51(6):1019-78. PubMed ID: 11661650
    [No Abstract]   [Full Text] [Related]  

  • 42. Guidelines for research involving recombinant DNA molecules.
    U.S. National Institutes of Health
    Fed Regist; 1983 Jun; 48(106):24556-81. PubMed ID: 11655244
    [No Abstract]   [Full Text] [Related]  

  • 43. Public regulation of recombinant dna gene therapy.
    McGarity TO; Shapiro SA
    J Leg Med; 1982 Jun; 3(2):185-210. PubMed ID: 6981676
    [No Abstract]   [Full Text] [Related]  

  • 44. Biotechnology regulation: White House holds the ring.
    Beardsley T
    Nature; 1985 Jan; 313(5998):85. PubMed ID: 11653580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of the Human Genome Project at the interface between patent and FDA laws.
    Cunningham BC
    Risk; 1996; 7(3):253-66. PubMed ID: 11655078
    [No Abstract]   [Full Text] [Related]  

  • 46. Gene treatments for human illness may be tried soon.
    Angier N
    N Y Times Web; 1990 Aug; ():A1, A12. PubMed ID: 11646772
    [No Abstract]   [Full Text] [Related]  

  • 47. A house divided.
    Cohen S
    Washington Post; 1997 Oct; ():12-17, 24-29. PubMed ID: 11647257
    [No Abstract]   [Full Text] [Related]  

  • 48. Industry gene-splice field tests approved.
    Miller JA
    Sci News; 1984 Jun; 125(23):356. PubMed ID: 11653555
    [No Abstract]   [Full Text] [Related]  

  • 49. Does genetic engineering need genetic engineers?: should the regulation of genetic engineering include a new professional discipline?
    Auchincloss S
    Boston Coll Environ Aff Law Rev; 1993; 20(1):37-63. PubMed ID: 11652234
    [No Abstract]   [Full Text] [Related]  

  • 50. Recombinant DNA Advisory Committee: minutes of meeting, 3 Oct 1988.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee
    Recomb DNA Tech Bull; 1988 Dec; 11(4):155-94. PubMed ID: 11644344
    [No Abstract]   [Full Text] [Related]  

  • 51. Recombinant DNA research; actions under guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1984 Apr; 49(81):17844-8. PubMed ID: 11655581
    [No Abstract]   [Full Text] [Related]  

  • 52. Gene-splice oversight.
    Parens E
    Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
    [No Abstract]   [Full Text] [Related]  

  • 53. Recombinant DNA: a case study in regulation of scientific research.
    Chalfant JC; Hartmann ME; Blakeboro A
    Ecol Law Q; 1979; 8(1):55-129. PubMed ID: 11665069
    [No Abstract]   [Full Text] [Related]  

  • 54. Firm gets NIH panel's approval for judge-barred DNA field test.
    Hilts PJ
    Washington Post; 1984 Jun; ():A1, A10. PubMed ID: 11646391
    [No Abstract]   [Full Text] [Related]  

  • 55. Regulation as facilitation: negotiating the genetic revolution.
    Black J
    Mod Law Rev; 1998 Sep; 61(5):621-60. PubMed ID: 14518446
    [No Abstract]   [Full Text] [Related]  

  • 56. Ethics as rule systems: the case of genetically engineered organisms.
    Jaeger CC; Rust AJ
    Inquiry; 1994 Mar; 37(1):65-84. PubMed ID: 11658187
    [No Abstract]   [Full Text] [Related]  

  • 57. Biotech's stalled revolution.
    Schneider K
    N Y Times Mag; 1986 Nov; ():42-44, 47-48+. PubMed ID: 11649783
    [No Abstract]   [Full Text] [Related]  

  • 58. Recombinant DNA research; actions under guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1987 Aug; 52(163):31848-50. PubMed ID: 11645639
    [No Abstract]   [Full Text] [Related]  

  • 59. Recombinant DNA research; proposed actions under guidelines; notice.
    U.S. National Institutes of Health
    Fed Regist; 1988 Dec; 53(251):53262-9. PubMed ID: 11655924
    [No Abstract]   [Full Text] [Related]  

  • 60. Institutional biosafety committees and the inadequacies of risk regulation.
    Bereano PL
    Sci Technol Human Values; 1984; 9(4):16-34. PubMed ID: 11649608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.